131 related articles for article (PubMed ID: 38161050)
1. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction (PCR) detection of B cell clonality in Sjögren's syndrome patients: a diagnostic tool of clonal expansion.
Guzmán LM; Castillo D; Aguilera SO
Clin Exp Immunol; 2010 Jul; 161(1):57-64. PubMed ID: 20408860
[TBL] [Abstract][Full Text] [Related]
3. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
4. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
5. [Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis].
Tiemann M; Asbeck R; Wacker HH
Pathologe; 1996 Jul; 17(4):289-95. PubMed ID: 8927595
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development.
Jordan R; Diss TC; Lench NJ; Isaacson PG; Speight PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):723-9. PubMed ID: 7621030
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
[TBL] [Abstract][Full Text] [Related]
8. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
[TBL] [Abstract][Full Text] [Related]
9. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
[TBL] [Abstract][Full Text] [Related]
10. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
12. A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.
Notarstefano C; Croia C; Pontarini E; Lucchesi D; Sutcliffe N; Tappuni A; Donati V; Pitzalis C; Baldini C; Bombardieri M
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):145-149. PubMed ID: 30156540
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma and Sjögren's syndrome. An immunopathological study of 113 patients.
Janin A; Morel P; Quiquandon I; Farre I; Hatron PY; Bauters F; Gosselin B
Clin Exp Rheumatol; 1992; 10(6):565-70. PubMed ID: 1483307
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Stratification in Primary Sjögren's Syndrome Reveals Novel Immune Cell Alterations in Patients' Minor Salivary Glands.
Bharaj TK; Aqrawi LA; Fromreide S; Jonsson R; Brun JG; Appel S; Skarstein K
Front Immunol; 2021; 12():701581. PubMed ID: 34322130
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjögren syndrome with and without lymphoma.
Johnsen SJ; Berget E; Jonsson MV; Helgeland L; Omdal R; Jonsson R
J Rheumatol; 2014 Nov; 41(11):2214-22. PubMed ID: 25274895
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma?
Nezos A; Skarlis C; Psarrou A; Markakis K; Garantziotis P; Papanikolaou A; Gravani F; Voulgarelis M; Tzioufas AG; Koutsilieris M; Moutsopoulos HM; Kotsifaki E; Mavragani CP
Front Immunol; 2021; 12():683623. PubMed ID: 34220834
[TBL] [Abstract][Full Text] [Related]
17. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
Fragkioudaki S; Mavragani CP; Moutsopoulos HM
Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
[TBL] [Abstract][Full Text] [Related]
18. Analysis of B-cell clonality in the hepatic tissue of patients with Sjögren's syndrome.
Tokuno T; Takahashi H; Suzuki C; Yamamoto M; Naishiro Y; Sugaya A; Sakamoto H; Imai K
Scand J Rheumatol; 2003; 32(5):268-72. PubMed ID: 14690138
[TBL] [Abstract][Full Text] [Related]
19. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
20. Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.
Christodoulou MI; Kapsogeorgou EK; Moutsopoulos NM; Moutsopoulos HM
Am J Pathol; 2008 Nov; 173(5):1389-96. PubMed ID: 18818377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
